Gallantt Ispat Limited Strong Financial Growth and Board Updates for Q4 FY 2026

Gallantt Ispat Limited reported strong growth for the quarter and year ended March 31, 2026, with the company achieving ₹12,283.08 lakh in net profit for the final quarter. The Board has recommended a final dividend of 20% (₹2 per share) for the fiscal year. Additionally, the company announced key leadership transitions, including the resignation of two Independent Directors and the appointment of two new Independent Directors to the Board.

Robust Financial Performance

Gallantt Ispat Limited demonstrated consistent financial momentum in the fiscal year ending March 31, 2026. The company recorded an annual net profit of ₹48,426.83 lakh, reflecting a solid performance compared to the previous year. For the final quarter (Q4) of FY2026, the company achieved a net profit of ₹12,283.08 lakh on a total income of ₹122,933.68 lakh. Earnings per share (Basic) stood at ₹20.07 for the full financial year.

Dividend Recommendation

The Board of Directors has recommended a final dividend of 20%, amounting to ₹2 per equity share with a face value of ₹10 each for the financial year 2025-26. This dividend payout is subject to the approval of shareholders at the upcoming Annual General Meeting.

Strategic Leadership Changes

The company announced significant restructuring at the Board level. Independent Directors Mrs. Smita Modi and Mr. Pankaj Khanna have stepped down from their positions effective from the close of business hours on May 5, 2026, citing personal reasons including work pressure and time constraints.

To ensure continued strong corporate governance, the Board has appointed Mr. Sanjay Kumar Jain and Mr. Kishore Pariyar as Additional Directors, categorized as Non-Executive Independent Directors, for a term of 5 years. These appointments are subject to the approval of the company’s members at the next general meeting.

Committee Reconstitutions

Following these leadership changes, the company has reconstituted several key committees, including the Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee, to maintain operational excellence and oversight.

Source: BSE

Previous Article

Sun Pharmaceutical Industries Limited Strategic Acquisition of Organon Business

Next Article

Gallantt Ispat Limited Strong Financial Growth and Strategic Board Changes